Wegovy, a prescription medication developed by Novo Nordisk, has garnered significant attention in the world of weight management and obesity treatment. This medication, which received approval from the U.S. Food and Drug Administration (FDA) in 2021, represents a novel approach in the battle against obesity, a condition affecting a substantial portion of the global population and associated with numerous health risks.